December 18, 2012 — ClearCanvas Inc. has rolled out integration between the ClearCanvas open source picture archiving and communication system (PACS) and workstation and the Tumor Imaging Metrics Core (TIMC) clinical trials system developed at Massachusetts General Hospital for use in managing clinical trials across multiple institutions.

ClearCanvas' software development platform allows innovators to easily build specialized plug-ins to extend the functionality of their products. Because the platform provides all the required image visualization and management services, innovators can focus on the specifics of their respective core competencies.

"We could not find off-the-shelf commercial software that met our requirements, so we decided to build custom tools designed to our own specifications for making protocol-driven measurements for cancer clinical trials and to electronically link these measurements and images to the Web-based workflow management and reporting system that we developed for our Tumor Imaging Metrics Core," said Gordon J. Harris, Ph.D., co-director of TIMC. "By creating plug-in software modules within an open source radiology imaging environment, we were able to build our own custom-designed measurement tools and upload results directly to our Web-based tracking system to create a comprehensive and integrated solution that can serve as a common platform across multiple cancer centers."

Harris said that with an integrated system that manages all aspects of clinical trials measurements, the TIMC has been able to provide efficient and reliable tumor measurements, with rapid turnaround time, across multiple hospitals. TIMC, which is used by hospitals comprising the Dana-Farber/Harvard Cancer Center, can deliver improved quality tumor metrics for oncologists, with less effort and disruption for oncology coordinators and radiologists, helping ensure that patients are appropriately qualified for participation criteria in clinical trials.

"We are very excited about what the TIMC has done," said Norman Young, CEO of ClearCanvas. "This integration has demonstrated exactly what the ClearCanvas platform is intended for. It has enabled a team of innovators to quickly and easily build and integrate new specialized tools without worrying about building the PACS to host them, saving time and resources."

For more information: www.clearcanvas.ca


Related Content

News | Prostate Cancer

Nov. 10, 2025 — Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a ...

Time November 11, 2025
arrow
Feature | Teleradiology | Kyle Hardner

Once viewed as a solution for after-hours coverage, teleradiology is rapidly expanding into a critical part of radiology ...

Time November 06, 2025
arrow
News | Digital Pathology

Sept. 8, 2025 — Pathology plays a crucial role in the diagnosis of a variety of diseases, particularly cancer, through ...

Time September 11, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

July 2, 2025 — Philips has received FDA 510(k) clearance for SmartSpeed Precise1 MR’s latest deep learning ...

Time July 03, 2025
arrow
News | Imaging Software Development

June 12, 2025 — GE HealthCare has announced the combination of GE HealthCare’s proprietary features and algorithms with ...

Time June 12, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

May 29, 2025 — Hyperfine, Inc., producer of the world’s first FDA-cleared AI-powered portable MRI system for the brain — ...

Time May 29, 2025
arrow
News | FDA

February 12, 2024 — Proscia, a leading provider of digital and computational pathology solutions, has received 510(k) ...

Time February 12, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

December 20, 2023 — Terran Biosciences, Inc., a biotech platform company developing therapeutics and technologies for ...

Time December 20, 2023
arrow
News | Artificial Intelligence

September 7, 2023 — Paige, a provider of end-to-end digital pathology solutions and clinical AI, has announced a ...

Time September 07, 2023
arrow
News | Radiology Business

July 27, 2023 — Privately-held biotech company TAE Life Sciences has announced that its board of directors has appointed ...

Time July 27, 2023
arrow
Subscribe Now